Eya Caridad Rodríguez-Pupo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eya Caridad Rodríguez-Pupo has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Bertha Espinoza
Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México C.P. 04510, Mexico
2 shared publications - Alberto Martínez Muñoz
FS SCIENTIA PHARMA S.A. de C.V (Authorized Third Party), San Luis Potosí, México
1 shared publication - Alejandro Dorazco-González
Institute of Chemistry, National Autonomous University of Mexico, Mexico City 04510, Mexico
1 shared publication - Alma Delia Paz-González
Laboratorio de Biotecnologia Farmaceutica, Centro de Biotecnologia Genomica, Instituto Politecnico Nacional, Reynosa 88710, Mexico
1 shared publication - Alma K. Esteban Covarrubias
Institute of Chemistry, National Autonomous University of Mexico, Mexico City, 04510, Mexico
1 shared publication - Berenice Prestegui Martel
Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
1 shared publication
Latest Publications
- 17 September 2025
- Published by Bentham Science Publishers Ltd. in Medicinal Chemistry
- Vol. 21
In Vitro Evaluation of p-Toluenesulfonyl Hydrazones as Anti-Trypanosoma cruzi and Leishmanicidal Agents
Introduction: Neglected tropical diseases (NTDs), such as Chagas disease (CD) and Cutaneous Leishmaniasis (CL), are significant global health concerns. The limited number of treatments and their severe adverse effects worsen the situation. Therefore, the development of molecules as a new pharmacological alternative is necessary. This work aimed to obtain new p- Toluenesulfonyl hydrazones derivatives to determine their potential antiparasitic activity against Trypanosoma cruzi (T. cruzi) and Leishmania mexicana (L. mexicana). Methods: Compounds were synthesized by condensing p-Toluenesulfonyl hydrazide with aromatic aldehydes using acetic acid as a catalyst. All compounds were structurally elucidated using infrared (IR) spectroscopy, proton and carbon nuclear magnetic resonance (¹H and ¹³C NMR), and Ultra-Performance Liquid Chromatography-tandem Mass Spectrometry (UPLCMS). The Queretaro (Qro) strain of T. cruzi and the M379 strain of L. mexicana were used for in vitro assays. Results: Compound pT-21 (IC50= 49.6 μM) was the most active agent against the T. cruzi Qro strain. Meanwhile, compounds pT-15 and pT-21 inhibited the proliferation of L. mexicana promastigotes with an IC50 value of 59.2 and 13.8 μM, respectively. In addition, these compounds had low cytotoxic effects against Vero cell lines (CC50 values >100 μM). Discussion: In this study, compound pT-21 inhibited the proliferation of T. cruzi and L. mexicana in vitro. Its activity is attributed to the reactivity of the 5-nitrofuran ring (present in other drugs such as nifurtimox). Future research could focus on identifying the pharmacological target of compound pT-21 to facilitate rational drug design and enhance its potency against these parasites. Conclusion: In summary, these results show that p-Toluenesulfonyl hydrazones serve as a scaffold to aid in the development of potent and selective agents against T. cruzi and L. mexicana.
- 17 September 2025
- Published by Bentham Science Publishers Ltd. in Medicinal Chemistry
- Vol. 21
In Vitro Evaluation of p-Toluenesulfonyl Hydrazones as Anti-Trypanosoma cruzi and Leishmanicidal Agents
Introduction: Neglected tropical diseases (NTDs), such as Chagas disease (CD) and Cutaneous Leishmaniasis (CL), are significant global health concerns. The limited number of treatments and their severe adverse effects worsen the situation. Therefore, the development of molecules as a new pharmacological alternative is necessary. This work aimed to obtain new p- Toluenesulfonyl hydrazones derivatives to determine their potential antiparasitic activity against Trypanosoma cruzi (T. cruzi) and Leishmania mexicana (L. mexicana). Methods: Compounds were synthesized by condensing p-Toluenesulfonyl hydrazide with aromatic aldehydes using acetic acid as a catalyst. All compounds were structurally elucidated using infrared (IR) spectroscopy, proton and carbon nuclear magnetic resonance (¹H and ¹³C NMR), and Ultra-Performance Liquid Chromatography-tandem Mass Spectrometry (UPLCMS). The Queretaro (Qro) strain of T. cruzi and the M379 strain of L. mexicana were used for in vitro assays. Results: Compound pT-21 (IC50= 49.6 μM) was the most active agent against the T. cruzi Qro strain. Meanwhile, compounds pT-15 and pT-21 inhibited the proliferation of L. mexicana promastigotes with an IC50 value of 59.2 and 13.8 μM, respectively. In addition, these compounds had low cytotoxic effects against Vero cell lines (CC50 values >100 μM). Discussion: In this study, compound pT-21 inhibited the proliferation of T. cruzi and L. mexicana in vitro. Its activity is attributed to the reactivity of the 5-nitrofuran ring (present in other drugs such as nifurtimox). Future research could focus on identifying the pharmacological target of compound pT-21 to facilitate rational drug design and enhance its potency against these parasites. Conclusion: In summary, these results show that p-Toluenesulfonyl hydrazones serve as a scaffold to aid in the development of potent and selective agents against T. cruzi and L. mexicana.
- Open Access
- 8 April 2025
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 54 (15) , 6043-6059
Tetranuclear and dinuclear Cu(ii) complexes with risedronate as anti-Trypanosoma cruzi and anti-Leishmania mexicana agents. Synthesis, crystal structures, and biological evaluation
Two novel water-soluble polynuclear Cu(ii)–risedronate complexes were synthesized, described structurally by single-crystal X-ray diffraction, and studied as antiparasitic agents against Trypanosoma cruzi and Leishmania mexicana.
- 8 April 2025
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 54 (15) , 6043-6059
Open AccessTetranuclear and dinuclear Cu(ii) complexes with risedronate as anti-Trypanosoma cruzi and anti-Leishmania mexicana agents. Synthesis, crystal structures, and biological evaluation
Two novel water-soluble polynuclear Cu(ii)–risedronate complexes were synthesized, described structurally by single-crystal X-ray diffraction, and studied as antiparasitic agents against Trypanosoma cruzi and Leishmania mexicana.